Results 231 to 240 of about 772,279 (379)

Evaluation of left ventricular systolic function in opium users by strain echocardiography. [PDF]

open access: yesESC Heart Fail
Mohammadi K   +5 more
europepmc   +1 more source

Prognostic implications of functional tricuspid regurgitation in asymptomatic degenerative mitral regurgitation

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Functional tricuspid regurgitation (FTR) associated with degenerative mitral regurgitation (DMR) accentuates the severity of heart failure and is a marker of poor prognosis. Little is known about FTR associated with asymptomatic DMR. Methods and results The study included 1249 asymptomatic patients with moderate or severe DMR from the ...
Christophe Tribouilloy   +16 more
wiley   +1 more source

Quantitative Echocardiography Improves Resident Assessment of Left Ventricular Systolic Function. [PDF]

open access: yesJ Educ Perioper Med, 2022
Wu AH   +7 more
europepmc   +1 more source

T1 mapping and major cardiovascular events in non‐ischaemic dilated cardiomyopathy: a systematic review and meta‐analysis

open access: yesESC Heart Failure, EarlyView.
In NIDCM patients, native T1 mapping and ECV were associated with increased risk of the composite primary endpoint of MACE and the secondary endpoint of heart failure and arrhythmic‐related events. Patients who experienced MACE had higher values of both T1 mapping and ECV.
Federico Marchini   +9 more
wiley   +1 more source

Left ventricular systolic function after inhalation of beta-2 agonists in healthy athletes. [PDF]

open access: yesSci Rep
Persch H   +10 more
europepmc   +1 more source

Immune Checkpoint Inhibitors and Cardiovascular Adverse Events

open access: yesESC Heart Failure, EarlyView.
Abstract In the last years, we assisted to a tremendous increase in therapeutic options for the management of cancers, with immunotherapy at the forefront of this innovation. Immune checkpoint inhibitors (ICIs) have been developed to enhance the activity of the immune system against cancer cells (1) and the number of approvals for ICIs has rapidly ...
Maria Luisa De Perna   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy